Skip to content

Cessation in Non-Daily Smokers

Cessation in Non-Daily Smokers: A RCT of NRT With Ecological Momentary Assessment

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02168855
Acronym
QUITS
Enrollment
505
Registered
2014-06-20
Start date
2015-06-30
Completion date
2019-01-31
Last updated
2020-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Smoking

Keywords

Smoking cessation, Non-daily smokers, Ecological Momentary Assessment, nicotine replacement therapy

Brief summary

The purpose of this study is to examine the effect of as-needed oral Nicotine Replacement Therapy (NRT) - 2 mg nicotine gum - for smoking cessation in non-daily, or intermittent, smokers, and to study the process of relapse in ITS, using Ecological Momentary Assessment (EMA).

Detailed description

Our aim is to study the effect of as-needed oral Nicotine Replacement Therapy (NRT) - 2 mg nicotine gum - for smoking cessation in non-daily, or intermittent, smokers (ITS), and to study the process of relapse in ITS, using Ecological Momentary Assessment (EMA). This is a double-blind, randomized, placebo-controlled trial of oral NRT for smoking cessation in ITS. 600 ITS who are interested in quitting will be recruited through multiple channels. Enrollees will be randomized 1:1 to active 2 mg nicotine gum or an inert control gum. Participants will attend 6 sessions with brief behavioral support, with a planned quit day at week 2. Short and long term abstinence will be assessed and biochemically validated. EMA data collection includes two weeks of baseline data on ad lib smoking patterns and 6 weeks of post-quit data. This will capture data on craving, withdrawal, and relapse among ITS, and relate relapse contexts to baseline smoking patterns.

Interventions

DRUGactive nicotine gum

2 mg, standard over-the-counter nicotine replacement therapy gum

Standard behavioral therapy for smoking cessation

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
Brian Primack
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years old or older * Smoking for at least 3 years * Smoking non-daily for at least one year (\< or = 27 days/month) * Smoke at least weekly * Intention to quit smoking within the next month and a desire to receive behavioral and medication treatment * Willing and able to come to the laboratory for 8 visits over a 14-week period, as well as a ninth and final visit 6 months after their quit date * Willing to monitor behavior via an electronic diary for 8 weeks * Able to read and write English (in order to understand questionnaires and study instructions)

Exclusion criteria

* Regular use of any form of tobacco other than cigarettes * Recent or severe mental illness (uncontrolled severe depression or mood symptoms, active hallucinations, and or hospitalization in the past month for a psychiatric condition) * Night and/or 'swing' shift work (which complicates EMA schedules) * Known plans to relocate or move from the Pittsburgh area within the coming 6 months * Received cessation treatment within past year * Use of bupropion or varenicline in past 2 months * Past use of nicotine gum (to avoid un-blinding) * Contraindication to NRT * (for women) Current pregnancy or breastfeeding or plan to become pregnant during the next 2 months * Member of the same household already participating

Design outcomes

Primary

MeasureTime frameDescription
Smoking Cessation, Continuous 6-month Abstinenceup to week 24Long term abstinence assessed and biochemically validated. The results reported are the number of participants self-reporting continuous abstinence throughout the 6-month, post-quit follow-up period. To be considered abstinent, a participant must have self-reported having not smoked during this period, demonstrated carbon monoxide levels less than or equal to 3 at each study visit, and cotinine values assessed via urinalysis at levels less than or equal to 25 ng/ml.

Secondary

MeasureTime frameDescription
Characteristics of Quit and Relapse Process - CravingSix-week post-quit periodEcological Momentary Assessment (EMA) methods will be used to study the craving, withdrawal, and relapse processes among ITS and relate relapse contexts to baseline smoking patterns. This measure assessed the intensity of craving experienced by participants during their attempt to quit smoking, via self-report. To ensure the results were not influenced by the use of active nicotine replacement gum, only the participants receiving inactive gum (containing no nicotine) are included in this analysis. The scale's range was 0-100, with higher values reflecting higher levels of self-reported craving (maximum score of 100), whereas a score of 0 indicates no craving. Background craving is defined as that experienced when a participant was not smoking or feeling a temptation to smoke. Temptations to smoke refers to situations where a participant was tempted to smoke and did, or tempted to and did not.
Characteristics of Quit and Relapse Process - Negative AffectSix-week post-quit periodEcological Momentary Assessment (EMA) methods will be used to study the craving, withdrawal, and relapse processes among ITS and relate relapse contexts to baseline smoking patterns. This measure assesses the intensity of negative affect participants experienced during their attempt to quit smoking. To ensure the results were not influenced by the use of active nicotine replacement gum, only the participants receiving inactive gum (containing no nicotine) are included in this analysis. The scale's range was 0-100, with higher values reflecting higher levels of self-reported negative affect (maximum score of 100), whereas a score of 0 would indicate no negative affect. 50 indicates the population mean with a standard deviation of 10. Background reports are defined as those experienced when a participant was not smoking or feeling a temptation to smoke. Temptations to smoke refers to situations where a participant was tempted to smoke and did, or tempted to and did not.
Characteristics of Quit and Relapse Process - Saw No Smoking CuesSix-week post-quit periodEcological Momentary Assessment (EMA) methods will be used to study the craving, withdrawal, and relapse processes among ITS and relate relapse contexts to baseline smoking patterns.To ensure the results were not influenced by the use of active nicotine replacement gum, only the participants receiving inactive gum (containing no nicotine) are included in this analysis. This measure reports the percentage of instances during which participants were not exposed to physical cues to smoke, such as cigarettes, ashtrays, or lighters), when experiencing temptations to smoke compared to experiencing no temptations to smoke. Background reports are defined as those experienced when a participant was not smoking or feeling a temptation to smoke. Temptations to smoke refers to situations where a participant was tempted to smoke and did, or tempted to and did not.
Characteristics of Quit and Relapse Process - No Others Smoking NearbySix-week post-quit periodEcological Momentary Assessment (EMA) methods will be used to study the craving, withdrawal, and relapse processes among ITS and relate relapse contexts to baseline smoking patterns. To ensure the results were not influenced by the use of active nicotine replacement gum, only the participants receiving inactive gum (containing no nicotine) are included in this analysis. This measure reports the percentage of instances during which participants were not exposed to others smoking nearby, when experiencing temptations to smoke compared to experiencing no temptations to smoke. Background reports are defined as those experienced when a participant was not smoking or feeling a temptation to smoke. Temptations to smoke refers to situations where a participant was tempted to smoke and did, or tempted to and did not.

Countries

United States

Participant flow

Pre-assignment details

While 505 participants were enrolled in and began the study, only 369 of these were ultimately randomized to the active nicotine gum or inactive (placebo) gum arms. Those who were not randomized due to either participant-initiated drop out (n=36), research-team-initiated withdrawal due to noncompliance (n=83), or loss to followup (n=17).

Participants by arm

ArmCount
Active Nicotine Gum
active nicotine gum: 2 mg, standard over-the-counter nicotine replacement therapy gum Standard behavioral therapy: Standard behavioral therapy for smoking cessation
181
Inactive Gum
Standard behavioral therapy: Standard behavioral therapy for smoking cessation
188
Total369

Baseline characteristics

CharacteristicInactive GumActive Nicotine GumTotal
Age, Continuous45.87 years
STANDARD_DEVIATION 15.02
42.72 years
STANDARD_DEVIATION 13.76
44.32 years
STANDARD_DEVIATION 14.48
Cigarettes smoked per day on average, assessed over the last 28 days, including all days1.9 cigarettes per day
STANDARD_DEVIATION 1.5
1.8 cigarettes per day
STANDARD_DEVIATION 1.5
1.9 cigarettes per day
STANDARD_DEVIATION 1.5
Cigarettes smoked per day on average, assessed over the last 28 days, including only smoking days3.9 cigarettes per day
STANDARD_DEVIATION 2.9
3.3 cigarettes per day
STANDARD_DEVIATION 2
3.6 cigarettes per day
STANDARD_DEVIATION 2.5
Ethnicity (NIH/OMB)
Hispanic or Latino
9 Participants11 Participants20 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
179 Participants170 Participants349 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants0 Participants1 Participants
Race (NIH/OMB)
Asian
2 Participants6 Participants8 Participants
Race (NIH/OMB)
Black or African American
81 Participants67 Participants148 Participants
Race (NIH/OMB)
More than one race
8 Participants11 Participants19 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
3 Participants3 Participants6 Participants
Race (NIH/OMB)
White
93 Participants94 Participants187 Participants
Sex: Female, Male
Female
102 Participants108 Participants210 Participants
Sex: Female, Male
Male
86 Participants73 Participants159 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 1810 / 188
other
Total, other adverse events
93 / 18165 / 188
serious
Total, serious adverse events
9 / 18114 / 188

Outcome results

Primary

Smoking Cessation, Continuous 6-month Abstinence

Long term abstinence assessed and biochemically validated. The results reported are the number of participants self-reporting continuous abstinence throughout the 6-month, post-quit follow-up period. To be considered abstinent, a participant must have self-reported having not smoked during this period, demonstrated carbon monoxide levels less than or equal to 3 at each study visit, and cotinine values assessed via urinalysis at levels less than or equal to 25 ng/ml.

Time frame: up to week 24

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Active Nicotine GumSmoking Cessation, Continuous 6-month Abstinence13 Participants
Inactive GumSmoking Cessation, Continuous 6-month Abstinence10 Participants
p-value: 0.4695% CI: [0.58, 3.29]Regression, Logistic
Secondary

Characteristics of Quit and Relapse Process - Craving

Ecological Momentary Assessment (EMA) methods will be used to study the craving, withdrawal, and relapse processes among ITS and relate relapse contexts to baseline smoking patterns. This measure assessed the intensity of craving experienced by participants during their attempt to quit smoking, via self-report. To ensure the results were not influenced by the use of active nicotine replacement gum, only the participants receiving inactive gum (containing no nicotine) are included in this analysis. The scale's range was 0-100, with higher values reflecting higher levels of self-reported craving (maximum score of 100), whereas a score of 0 indicates no craving. Background craving is defined as that experienced when a participant was not smoking or feeling a temptation to smoke. Temptations to smoke refers to situations where a participant was tempted to smoke and did, or tempted to and did not.

Time frame: Six-week post-quit period

Population: This is the subset of placebo arm ITS participants who had achieved initial abstinence. These participants all submitted at least one background and one temptation report. To ensure the results were not influenced by using active nicotine gum, only participants receiving inactive gum (containing no nicotine) are included in this analysis.

ArmMeasureGroupValue (LEAST_SQUARES_MEAN)Dispersion
Active Nicotine GumCharacteristics of Quit and Relapse Process - CravingBackground16.68 score on a scaleStandard Error 1.61
Active Nicotine GumCharacteristics of Quit and Relapse Process - CravingTemptations to smoke57.09 score on a scaleStandard Error 2.5
p-value: <0.000195% CI: [1.83, 1.98]Mixed Models Analysis
Secondary

Characteristics of Quit and Relapse Process - Negative Affect

Ecological Momentary Assessment (EMA) methods will be used to study the craving, withdrawal, and relapse processes among ITS and relate relapse contexts to baseline smoking patterns. This measure assesses the intensity of negative affect participants experienced during their attempt to quit smoking. To ensure the results were not influenced by the use of active nicotine replacement gum, only the participants receiving inactive gum (containing no nicotine) are included in this analysis. The scale's range was 0-100, with higher values reflecting higher levels of self-reported negative affect (maximum score of 100), whereas a score of 0 would indicate no negative affect. 50 indicates the population mean with a standard deviation of 10. Background reports are defined as those experienced when a participant was not smoking or feeling a temptation to smoke. Temptations to smoke refers to situations where a participant was tempted to smoke and did, or tempted to and did not.

Time frame: Six-week post-quit period

Population: This is the subset of placebo arm ITS participants who had achieved initial abstinence. These participants all submitted at least one background and one temptation report. To ensure the results were not influenced by using active nicotine gum, only participants receiving inactive gum (containing no nicotine) are included in this analysis.

ArmMeasureGroupValue (LEAST_SQUARES_MEAN)Dispersion
Active Nicotine GumCharacteristics of Quit and Relapse Process - Negative AffectBackground49.13 T-scoreStandard Error 0.63
Active Nicotine GumCharacteristics of Quit and Relapse Process - Negative AffectTemptations to smoke51.96 T-scoreStandard Error 0.84
p-value: <0.000195% CI: [1.51, 1.83]Mixed Models Analysis
Secondary

Characteristics of Quit and Relapse Process - No Others Smoking Nearby

Ecological Momentary Assessment (EMA) methods will be used to study the craving, withdrawal, and relapse processes among ITS and relate relapse contexts to baseline smoking patterns. To ensure the results were not influenced by the use of active nicotine replacement gum, only the participants receiving inactive gum (containing no nicotine) are included in this analysis. This measure reports the percentage of instances during which participants were not exposed to others smoking nearby, when experiencing temptations to smoke compared to experiencing no temptations to smoke. Background reports are defined as those experienced when a participant was not smoking or feeling a temptation to smoke. Temptations to smoke refers to situations where a participant was tempted to smoke and did, or tempted to and did not.

Time frame: Six-week post-quit period

Population: This is the subset of placebo arm ITS participants who had achieved initial abstinence. These participants all submitted at least one background and one temptation report. To ensure the results were not influenced by using active nicotine gum, only participants receiving inactive gum (containing no nicotine) are included in this analysis.

ArmMeasureGroupValue (NUMBER)
Active Nicotine GumCharacteristics of Quit and Relapse Process - No Others Smoking NearbyBackground90.42 percentage of assessments
Active Nicotine GumCharacteristics of Quit and Relapse Process - No Others Smoking NearbyTemptations to smoke66.82 percentage of assessments
p-value: <0.000195% CI: [0.15, 0.23]Regression, Logistic
Secondary

Characteristics of Quit and Relapse Process - Saw No Smoking Cues

Ecological Momentary Assessment (EMA) methods will be used to study the craving, withdrawal, and relapse processes among ITS and relate relapse contexts to baseline smoking patterns.To ensure the results were not influenced by the use of active nicotine replacement gum, only the participants receiving inactive gum (containing no nicotine) are included in this analysis. This measure reports the percentage of instances during which participants were not exposed to physical cues to smoke, such as cigarettes, ashtrays, or lighters), when experiencing temptations to smoke compared to experiencing no temptations to smoke. Background reports are defined as those experienced when a participant was not smoking or feeling a temptation to smoke. Temptations to smoke refers to situations where a participant was tempted to smoke and did, or tempted to and did not.

Time frame: Six-week post-quit period

Population: This is the subset of placebo arm ITS participants who had achieved initial abstinence. These participants all submitted at least one background and one temptation report. To ensure the results were not influenced by using active nicotine gum, only participants receiving inactive gum (containing no nicotine) are included in this analysis.

ArmMeasureGroupValue (NUMBER)
Active Nicotine GumCharacteristics of Quit and Relapse Process - Saw No Smoking CuesBackground83.64 percentage of assessments
Active Nicotine GumCharacteristics of Quit and Relapse Process - Saw No Smoking CuesTemptations to smoke59.11 percentage of assessments
p-value: <0.000195% CI: [0.14, 0.21]Regression, Logistic

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026